{"id":1013264,"date":"2026-10-23T20:03:04","date_gmt":"2026-10-24T00:03:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/"},"modified":"2026-10-23T20:03:04","modified_gmt":"2026-10-24T00:03:04","slug":"rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/","title":{"rendered":"RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ALISO VIEJO, Calif., Oct.  23, 2026  (GLOBE NEWSWIRE) &#8212; RxSight, Inc. (NASDAQ: RXST) today announced that on October 23, 2026, RxSight granted inducement stock options to purchase a total of 236,456 shares of RxSight\u2019s common stock to two new non-executive officer employees in connection with the commencement of their employment with RxSight. RxSight also agreed to grant inducement restricted stock units (RSUs) covering a total of 637,449 shares of RxSight\u2019s common stock to the same employees in connection with the commencement of their employment with RxSight, which RSUs are anticipated to be granted on or about November 3, 2026.<\/p>\n<p align=\"justify\">Each inducement stock option has an exercise price of $5.02 per share, which is equal to the closing price of a share of RxSight common stock on the grant date, and shall vest as follows, subject to continuing service: 25% of the shares subject to such inducement stock option shall vest on the one year anniversary of October 23, 2026, and one forty-eighth (1\/48th) of the shares subject to such inducement stock option shall vest monthly thereafter.<\/p>\n<p align=\"justify\">Each inducement RSU award shall vest as follows, subject to continuing service: one-sixth of the shares subject to the inducement RSU award shall vest on the first trading day on or after each of February 28, 2027, August 31, 2027, February 29, 2028, August 31, 2028, February 28, 2029, and August 31, 2029.<\/p>\n<p align=\"justify\">Each inducement award is subject to the terms of the RxSight, Inc. 2026 Inducement Equity Incentive Plan and related forms of agreements, and were granted as inducements material to these employees to enter into employment with RxSight in accordance with Nasdaq Listing Rule 5635(c)(4).<\/p>\n<p>\n        <strong>About RxSight, Inc. <\/strong>\n      <\/p>\n<p>RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The Light Adjustable Lens\u2122 system, comprised of the RxSight Light Adjustable Lens\u2122 products (LAL\u2122 and LAL+\u2122), RxSight Light Delivery Device\u2122 (LDD\u2122), and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rs02GM2BxdJ9K2DjgDWxR16dFFQp6bV7B1XO2uR6kNq-_nStI6BNkfZ3CHwYwE-ce9hZBXBQrQ4H_N-fZG7S6Q==\" rel=\"nofollow\" target=\"_blank\">www.rxsight.com<\/a>.<\/p>\n<p>Light Adjustable Lens\u2122, LAL\u2122, LAL+\u2122, Light Delivery Device\u2122 and LDD\u2122 are trademarks of RxSight, Inc.<\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Oliver Moravcevic<br \/>VP, Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Sqy_bgH2jGuiqvUm3QrXuqTPJy2Q1zHgKOyaNPG3xFClMrtSInrvsl69aRlkmxjgu7PCOi2Xz882lguZmljE33JtUQGJydoia8FOEpJgLF4=\" rel=\"nofollow\" target=\"_blank\"><u>omoravcevic@rxsight.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MjQ0OCM3OTE0MTM1IzIyMTAxNDU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjQ3MjY2YTktYTNkOS00M2I4LTlkNzgtOTYyYjI3MGE2OGZkLTEyMjE2OTgtMjAyNi0xMC0yNC1lbg==\/tiny\/RxSight-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ALISO VIEJO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) &#8212; RxSight, Inc. (NASDAQ: RXST) today announced that on October 23, 2026, RxSight granted inducement stock options to purchase a total of 236,456 shares of RxSight\u2019s common stock to two new non-executive officer employees in connection with the commencement of their employment with RxSight. RxSight also agreed to grant inducement restricted stock units (RSUs) covering a total of 637,449 shares of RxSight\u2019s common stock to the same employees in connection with the commencement of their employment with RxSight, which RSUs are anticipated to be granted on or about November 3, 2026. Each inducement stock option has an exercise price of $5.02 per share, which is equal to the closing price of a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1013264","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ALISO VIEJO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) &#8212; RxSight, Inc. (NASDAQ: RXST) today announced that on October 23, 2026, RxSight granted inducement stock options to purchase a total of 236,456 shares of RxSight\u2019s common stock to two new non-executive officer employees in connection with the commencement of their employment with RxSight. RxSight also agreed to grant inducement restricted stock units (RSUs) covering a total of 637,449 shares of RxSight\u2019s common stock to the same employees in connection with the commencement of their employment with RxSight, which RSUs are anticipated to be granted on or about November 3, 2026. Each inducement stock option has an exercise price of $5.02 per share, which is equal to the closing price of a &hellip; Continue reading &quot;RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-24T00:03:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MjQ0OCM3OTE0MTM1IzIyMTAxNDU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules\",\"datePublished\":\"2026-10-24T00:03:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\\\/\"},\"wordCount\":372,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MjQ0OCM3OTE0MTM1IzIyMTAxNDU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\\\/\",\"name\":\"RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MjQ0OCM3OTE0MTM1IzIyMTAxNDU=\",\"datePublished\":\"2026-10-24T00:03:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MjQ0OCM3OTE0MTM1IzIyMTAxNDU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MjQ0OCM3OTE0MTM1IzIyMTAxNDU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/","og_locale":"en_US","og_type":"article","og_title":"RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules - Market Newsdesk","og_description":"ALISO VIEJO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) &#8212; RxSight, Inc. (NASDAQ: RXST) today announced that on October 23, 2026, RxSight granted inducement stock options to purchase a total of 236,456 shares of RxSight\u2019s common stock to two new non-executive officer employees in connection with the commencement of their employment with RxSight. RxSight also agreed to grant inducement restricted stock units (RSUs) covering a total of 637,449 shares of RxSight\u2019s common stock to the same employees in connection with the commencement of their employment with RxSight, which RSUs are anticipated to be granted on or about November 3, 2026. Each inducement stock option has an exercise price of $5.02 per share, which is equal to the closing price of a &hellip; Continue reading \"RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-24T00:03:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MjQ0OCM3OTE0MTM1IzIyMTAxNDU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules","datePublished":"2026-10-24T00:03:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/"},"wordCount":372,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MjQ0OCM3OTE0MTM1IzIyMTAxNDU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/","name":"RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MjQ0OCM3OTE0MTM1IzIyMTAxNDU=","datePublished":"2026-10-24T00:03:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MjQ0OCM3OTE0MTM1IzIyMTAxNDU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MjQ0OCM3OTE0MTM1IzIyMTAxNDU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1013264","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1013264"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1013264\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1013264"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1013264"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1013264"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}